Back
Bicara Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
BCAX
Bicara Therapeutics
Last Price:
18.08
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is relatively stagnant and BCAX is experiencing slight selling pressure.
Bicara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.65 | Sell |
| 20-day SMA: | 22.12 | Sell |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 19.51 | Sell |
| 20-day EMA: | 20.67 | Sell |
| 50-day EMA: | 17.42 | Buy |
| 200-day EMA: | 7.31 | Buy |
Bicara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 30.37 | Sell |
| Chaikin Money Flow: | -17151 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 24.31) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
Bicara Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bicara Therapeutics Stock
Is Bicara Therapeutics Stock a Buy?
- Bicara Therapeutics share price is 18.09 while BCAX 8-day simple moving average is 19.65, which is a Sell signal.
- The stock price of BCAX is 18.09 while Bicara Therapeutics 20-day SMA is 22.12, which makes it a Sell.
- Bicara Therapeutics 50-day simple moving average is 0.00 while BCAX share price is 18.09, making it a Buy technically.
- BCAX stock price is 18.09 and Bicara Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
BCAX Technical Analysis vs Fundamental Analysis
Sell
20
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy or a Sell?
-
Bicara Therapeutics stock is rated a Sell
The current Bicara Therapeutics [BCAX] share price is $18.09. The Score for BCAX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Bicara Therapeutics Stock Info
Market Cap:
832.61M
Price in USD:
18.09
Share Volume:
415.06K
Bicara Therapeutics 52-Week Range
52-Week High:
28.09
52-Week Low:
17.41
Sell
20
Bicara Therapeutics (BCAX)
is a Sell
Bicara Therapeutics Share Price Forecast
-
What is the Bicara Therapeutics stock price today?
The Bicara Therapeutics stock price is 18.09 USD today. -
Will BCAX stock go up or go down?
Bicara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Bicara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bicara Therapeutics is overvalued.
Is Bicara Therapeutics Stock a Buy?
- Bicara Therapeutics share price is 18.09 while BCAX 8-day exponential moving average is 19.51, which is a Sell signal.
- The stock price of BCAX is 18.09 while Bicara Therapeutics 20-day EMA is 20.67, which makes it a Sell.
- Bicara Therapeutics 50-day exponential moving average is 17.42 while BCAX share price is 18.09, making it a Buy technically.
- BCAX stock price is 18.09 and Bicara Therapeutics 200-day simple moving average is 7.31, creating a Buy signal.
Fundamental Analysis of Bicara Therapeutics
Is Bicara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.26 per share.
Technical Analysis of Bicara Therapeutics
Should I short Bicara Therapeutics stock?
- BCAX Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Bicara Therapeutics is a Sell
- Bicara Therapeutics Relative Strength Index (RSI) is 30.37, which suggest Bicara Therapeutics is oversold
- The Bollinger Bands (25) for Bicara Therapeutics is (20.11 - 24.31), which suggest Bicara Therapeutics is a Buy
- The Bollinger Bands (100) for Bicara Therapeutics is ( - ), which suggest Bicara Therapeutics is a Buy
* Bicara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.